This is the authors' abstract. We don't add key points for this paper.
Countries and health providers are following the path Iceland9s deCODE Genetics blazed 5 years ago and combining health and genetic data on large populations. They promise to deliver personalized medicine, but will they? Some ethicists also worry that data won9t remain confidential and suggest that companies, which will play a role in some projects, should not be allowed to profit from people9s genetic heritage.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jocelyn Kaiser (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: